B. Riley covered Heska Corp (NASDAQ:HSKA), bumping its price target to $53.00 today
- Updated: September 25, 2016
Stating as potential downside of -0.03%, B. Riley bumped up the price target of Heska Corp (NASDAQ:HSKA) to $53.00
Previously on Wednesday September 21, 2016, B. Riley reported on Heska Corp (NASDAQ:HSKA) bumped up the target price from $0.00 to $53.00 that suggested a downside of -0.05%.
Yesterday Heska Corp (NASDAQ:HSKA) traded -0.40% lower at $54.46. Heska Corp’s 50-day average is $52.90 and its two hundred day average is $39.60. The last closing price is up 37.54% from the 200-day moving average, compared to the S&P 500 which has decreased -0.01% over the same period. Trade Volume was down over the average, with 94,798 shares of HSKA changing hands under the typical 100,917
Heska Corp has PE ratio of 55.18 with a 52 week low of $26.26 and a 52 week high of $57.41 and has a market cap of $0.
Also covering Heska Corp's stock price target, a total of 4 brokerages have issued a research note on the stock. The consensus target price is $39.88 with 1 equity analyst rating the company a strong buy, three firms rating the stock a buy, zero analysts rating the company a hold, 0 brokers rating the stock a underperform, and finally 0 brokerages rating the stock a sell.
About Heska Corp (NASDAQ:HSKA)
Heska Corporation develops, manufactures, markets, sells and supports veterinary products. The Company focuses on the canine and feline companion animal health markets. Its segments include Core Companion Animal Health segment, which includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, and single use products and services, such as heartworm diagnostic tests, heartworm preventive products, allergy immunotherapy products and allergy testing, and Other Vaccines, Pharmaceuticals and Products segment, which includes private label vaccine and pharmaceutical production, primarily for cattle but also for other animals, including small mammals. It offers blood testing instruments and supplies, digital imaging products, software and services, and single use products and services, such as in-clinic heartworm diagnostic tests, heartworm preventive products, allergy immunotherapy products and allergy testing.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.